Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate if early administration (i.e. within 12 weeks
after stroke) of Dysport® 500 U injections may delay the appearance or the progression of
upper limb symptomatic spasticity.
Phase:
Phase 4
Details
Lead Sponsor:
Ipsen
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA